Final Agenda for 2nd Annual Microbiome Discovery & Development Congress

Oxford Global is pleased to share with you the final agenda for the 2nd Annual Microbiome Discovery & Development Congress, to be held on the 7 - 8th June 2018 in Berlin.

 

Across two days, the congress will bring together over 100 delegates to explore and discuss the latest issues, trends and developments in the microbiome field. Our revamped program offers innovative case studies on a diverse range of microbiome-related topics, including small molecule drug development, the gut-brain axis, dermatology, inflammatory conditions, autoimmune disorders, and much more.

 

Do not miss out on presentations including:

 

• Targeting The Microbiome – Through A Regulatory Lens    
  Colette Shortt, Regulatory Director, Global Franchise Organisation, J&J Consumer
• Microbiome & Skin Aging, an Example of Dysbiosis     
  Lionel Breton, Scientific Director, Advanced Research, L’Oreal
• Functional Screening in Neurodegenerative Disorders
  Imke Mulder, Research Director, 4D Pharma

 

Register now and benefit from:

 

• Two exciting streams covering the discovery and development of microbiome therapeutics, each containing cutting-edge presentations from companies including J&J, GlaxoSmithKline, Biosortia, and AMAbiotics   
• An interactive workshop addressing the challenges involved in the commercialisation of microbiome therapeutics, including regulatory and IP concerns, collaboration and investment
• An in-depth industry perspective on recent and forthcoming developments in the field
• Dedicated networking opportunities to engage in scientific discussion with leading figures in the microbiome and drug discovery sector